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Background: Ruptured descending thoracic aortic aneurysm (rDTAA) is a cardiovascular catastrophe, associated with
high morbidity and mortality, which can be managed either by open surgery or thoracic endovascular aortic repair
(TEVAR). The purpose of this study is to retrospectively compare the mortality, stroke, and paraplegia rates after open
surgery and TEVAR for the management of rDTAA.
Methods: Patients with rDTAA treated with TEVAR or open surgery between 1995 and 2010 at seven institutions were
identified and included for analysis. The outcomes between both treatment groups were compared; the primary end point
of the study was a composite end point of death, permanent paraplegia, and/or stroke within 30 days after the
intervention. Multivariate logistic regression analysis was used to identify risk factors for the primary end point.
Results: A total of 161 patients with rDTAA were included, of which 92 were treated with TEVAR and 69 with open
surgery. The composite outcome of death, stroke, or permanent paraplegia occurred in 36.2% of the open repair group,
compared with 21.7% of the TEVAR group (odds ratio [OR], 0.49; 95% confidence interval [CI], .24-.97; P .044). The
30-day mortality was 24.6% after open surgery compared with 17.4% after TEVAR (OR, 0.64; 95% CI, .30-1.39; P 
.260). Risk factors for the composite end point of death, permanent paraplegia, and/or stroke in multivariate analysis
were increasing age (OR, 1.04; 95% CI, 1.01-1.08; P  .036) and hypovolemic shock (OR, 2.47; 95% CI, 1.09-5.60;
P  .030), while TEVAR was associated with a significantly lower risk of the composite end point (OR, 0.44; 95% CI,
.20-.95; P  .039). The aneurysm-related survival of patients treated with open repair was 64.3% at 4 years, compared
with 75.2% for patients treated with TEVAR (P  .191).
Conclusions: Endovascular repair of rDTAA is associated with a lower risk of a composite of death, stroke, and paraplegia,
compared with traditional open surgery. In rDTAA patients, endovascular management appears the preferred treatment
when this method is feasible. ( J Vasc Surg 2011;53:1210-6.)
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tThoracic aortic aneurysm rupture is a cardiovascular
catastrophe with an estimated incidence of 5.0 per 100,000
people per year.1,2 The yearly rate of aortic rupture, dissec-
tion, and/or death for aneurysms larger than 6 cm is
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1210round 15%,3-5 and only a small fraction of all patients with
uptured thoracic aortic aneurysms is admitted alive to the
mergency department.1 The prognosis of patients with
uptured thoracic aortic aneurysms that make it to the
ospital and undergo intervention is thought to be more
ealistic; however, mortality and morbidity rates in this
ubgroup remain substantial.6-8
The traditional treatment for ruptured descending tho-
acic aortic aneurysm (rDTAA), which account for approx-
mately 30% of all ruptured aneurysms of the thoracic
orta,1 has been for decades open surgical resection fol-
owed by interposition of a Dacron graft.6,7 Open surgical
epair of rDTAA is associated with high mortality rates, and
considerable number of surviving patients suffer from
isabling complications such as permanent paraplegia or
troke.6-9 Thoracic endovascular aortic repair (TEVAR)
ecently offers a less invasive alternative for the manage-
ent of descending thoracic aortic pathologies.10-12 Al-
hough TEVAR is increasingly being used for the man-
gement of acute thoracic aortic disease,13-16 it remains
nclear if endovascular repair reduces the mortality and
orbidity of rDTAA, due to the low incidence of this
mergency. The purpose of this multicenter study is to
ompare the mortality, stroke, and paraplegia rates be-
ween patients with rDTAA treated with open surgery and
EVAR.
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Study population. The following referral centers par-
ticipated in this project: Yale New Haven Hospital (New
Haven, Conn), Baylor College of Medicine (Houston,
Tex), Christine E. LynnHeart and Vascular Institute (Boca
Raton, Fla), Policlinico San Donato, Istituto Di Ricovero e
Cura a Carattere Scientifico (San Donato Milanese, Italy),
St. Antonius Hospital (Nieuwegein, The Netherlands),
Erasmus University Medical Center (Rotterdam, The
Netherlands), and the University Medical Center Utrecht
(Utrecht, The Netherlands). The study was approved by
the institutional review committee at all participating insti-
tutions. Patients with rDTAA treated with TEVAR or open
surgery between 1995 and 2010 were identified and in-
cluded for analysis. Ruptured aneurysm was defined as any
disruption of the aneurysmal aortic wall with an extravas-
cular collection of blood. The anatomic extent of the
aneurysm was located between the left subclavian artery
and the celiac axis in all cases.
Surgical techniques. At present, the participating
hospitals have established a protocol for admitted patients
with rDTAA in which endovascular repair has become the
preferred treatment. All endovascular procedures were per-
formed in the operating room under general anesthesia by
vascular and/or cardiothoracic surgeons. The following
endovascular devices were used: Gore TAG (GoreMedical,
Flagstaff, Ariz), Medtronic Talent (Medtronic, Santa Rosa,
Calif), or Medtronic Valiant (Medtronic). The endograft
diameter was oversized compared with the native aortic
landing zone diameter by 10% to 20%, as recommended by
the manufacturer. To ensure an adequate landing zone,
overstenting of the left subclavian and/or celiac artery was
required in some cases. Routine revascularization of the left
subclavian artery was not performed; this depended on the
preference of the surgeon, the vertebrobasilar circulation,
and the condition of the patient. Contraindications for
TEVAR have changed over the years and may differ be-
tween the different participating institutions and physi-
cians. Current contraindications typically include no prox-
imal or distal aortic neck, or an aortic diameter that is too
wide for commercially available thoracic endografts.
Open surgical procedures were typically performed by
cardiothoracic surgeons through a posterolateral thoracot-
omy in the fourth to sixth intercostal space using extracor-
poreal perfusion support, with a simple clamp technique or
hypothermic circulatory arrest. Indications for hypother-
mic circulatory arrest included the need to extend the
resection into the distal aortic arch or the entire descend-
ing thoracic aorta, or if the aortic pathology precluded the
use of aortic cross-clamping. Reimplantation of intercostal
arteries depended on the surgeon’s preference. Prophylac-
tic cerebrospinal fluid drainage during open surgery or
TEVAR was only performed if the patient was stable
enough and was thought to have an increased risk for spinal
cord ischemia.
End points and statistical analysis. The primary end
point of the study was a composite end point of death, termanent paraplegia, and/or stroke within 30 days after
he intervention. We defined stroke as a new central neu-
ologic deficit within 30 days after the aortic intervention,
onfirmed as an ischemic or hemorrhagic lesion on com-
uted tomography or magnetic resonance imaging of the
rain.
The individual components of the primary end point
ere analyzed as secondary end points. Secondary end
oints also included other complications, aortic reinterven-
ion within 30 days, hospital length of stay, and aneurysm-
elated survival during follow-up. Categorical variables
ere investigated using the 2 test or the Fisher’s exact test
nd continuous variables using the Student t test or Mann-
hitneyU test. Multivariate logistic regression analysis was
sed to investigate independent effects of baseline and
perating characteristics on the primary composite end
oint and 30-day mortality. Variables with a P value.2 in
nivariate analysis were integrated in the multivariate
egression model. Kaplan-Meier survival analysis was
sed to investigate the aneurysm-related survival during
ollow-upafterTEVARandopen surgical repair.Aneurysm-
elated death was defined as death within 30 days, or death
fter 30 days due to complications related to the aneurysm
nd/or intervention. Statistical analysis was performed us-
ng SPSS 15.0 software (SPSS, Inc, Chicago, Ill); a P va-
ue .05 was considered statistically significant.
ESULTS
Overall, 161 patients with rDTAA between 1995 and
009 were identified, of which 57.1% (n  92) underwent
EVAR and 42.9% (n  69) open surgical repair. Prior to
000, all admitted patients underwent open surgery (Fig 1),
ompared with 57.4% of patients between 2000 and 2004,
nd 10% of patients admitted from 2005 (P  .001). After
he first endovascular repair of rDTAA in 2001, the utiliza-
ig 1. Trends in management and 30-day mortality of ruptured
escending thoracic aortic aneurysm (rDTAA). The 30-day mor-
ality of rDTAA decreased over the years from 32.4% before 2000
o 21.4% between 2000 and 2004, and 15.0% between 2005 and
009 (P  .109). TEVAR, Thoracic endovascular aortic repair.ion of TEVAR for rDTAA rapidly increased (Fig 1).
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May 20111212 Jonker et alThemean age of patients treated with TEVARwas 69.4
years, compared with 64.8 years for patients treated with
open surgery (P .016; Table I). There were no significant
differences in gender or pre-existing comorbidities between
the TEVAR and open repair groups. The mean aneurysm
diameter of patients that received TEVAR was significantly
smaller than those receiving open surgery (55.5mm vs 69.5
mm; P  .001, Table I). Aneurysm repair was performed
within 24 hours in 89.4% of the open repair group and in
85.4% of the TEVAR group (P .49). Coverage of the left
subclavian artery was needed in 34.1% after TEVAR and
coverage of the celiac artery in 5.4%. Left carotid-subclavian
bypass was performed in three of the patients in which the
left subclavian artery was covered. Cerebrospinal fluid
drainage was performed in similar rates in both treatment
groups during the intervention (15.9% vs 18.7%; P .65).
Early outcomes. Overall, the 30-day mortality of
rDTAA decreased over the years from 32.4% before 2000 to
21.4% between 2000 and 2004, and 15.0% between 2005
and 2009 (P  .109; Fig 1). Among the patients treated
with open repair, the 30-day mortality was 24.6% (n 17),
compared with 17.4% (n  16) among patients treated
with TEVAR (odds ratio [OR], 0.64; 95% confidence
interval [CI], .30-1.39; P  .260). The composite out-
come of death, stroke, or permanent paraplegia occurred in
36.2% (n  25) of the open repair group, compared with
21.7% (n  20) of the TEVAR group (OR, 0.49; 95% CI,
0.24-0.97; P  .044). Permanent paraplegia occurred in
8.7% after open surgery, compared with 2.2% after TEVAR
(P .059; Table II). The death, stroke, and/or paraplegia
rates did not differ significantly between the participating
institutions.
Postoperative pulmonary complications (31.9% vs
Table I. Baseline characteristics
Open repa
N
Age (years) 64.8
Male gender 51
Comorbidities
Hypertension 42
Diabetes mellitus 15
Coronary artery disease 29
Chronic obstructive pulmonary disease 21
Chronic renal insufficiency 12
Carotid disease 8
Hyperlipidemia 20
Prior aortic repair 23
Presentation
Thoracic pain 47
Hemothorax 36
Hypovolemic shock 18
Aneurysm diameter (mm) 69.5
Associated dissection 10
Associated fistula 9
TEVAR, Thoracic endovascular aortic repair.
Prior aortic repair consisted of 29 prior abdominal aortic interventions and
abdominal and thoracic aortic intervention.17.4%; P  .032) and acute renal failure (24.6% vs 8.7%; t .006) were significantly increased in patients treated
ith open surgery compared with TEVAR (Table II).
ndoleak was diagnosed in 17.4% within the first 30 days
fter TEVAR (type 1A in seven patients, type 1B in three
atients, type 2 in five patients, and type three in one
atient). The median hospital length of stay for surviving
atients was 22 days (interquartile range, 26 days) in the
pen repair group, compared with 8 days (interquartile
ange, 10 days) in the TEVAR group (P  .001).
Multivariate analysis of end points. Independent
isk factors for the primary end point of death, stroke, or
ermanent paraplegia in multivariate analysis were increas-
ng age (OR, 1.04; 95% CI, 1.01-1.08; P  .036) and
ypovolemic shock (OR, 2.47; 95% CI, 1.09-5.60; P 
030), while TEVAR was associated with a significantly
ower risk of the composite end point (OR, 0.44; 95% CI,
.20-0.95; P  .039). The risk of death, stroke, and/or
ermanent paraplegia tended to increase after prior aortic
epair (OR, 2.15; 95% CI, 0.95-4.86; P .065; Table III).
ndependent predictors of 30-day mortality were hypovo-
emic shock at admission (OR, 2.63; 95% CI, 1.03-6.70;
 .044) and a prior aortic repair (OR, 2.65; 95% CI,
.08-6.47; P  .033; Table IV).
Aneurysm-related survival during follow-up. The
edian length of follow-up of patients that were alive at 30
ays was 34.5 months in the open repair group and 13.5
onths in the TEVAR group. After the first 30 days, seven
dditional patients in the open repair group died of com-
lications related to the aneurysm and/or intervention, and
ve patients in the TEVAR group. Causes of death in the
pen repair group were poor general condition and/or
ongestive heart failure related to surgical intervention (n
), multi-organ failure (n  2), sepsis (n  1), and unable
 69) TEVAR (n  92)
P value(%) N (%)
12.8) 69.4 (11.4) .016
73.9) 62 (67.4) .37
60.9) 48 (55.8) .53
21.7) 13 (15.3) .30
42.0) 38 (45.8) .64
30.4) 22 (25.0) .45
17.4) 13 (15.9) .80
11.6) 13 (15.7) .47
29.0) 23 (27.7) .86
33.3) 21 (23.1) .15
75.8) 62 (67.4) .26
52.2) 39 (43.8) .29
26.1) 21 (23.1) .66
17.4) 55.5 (20.4) .001
14.5) 13 (14.3) .97
13.0) 12 (13.2) .98
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and/or sepsis (n  3), aortic rupture (n  1), and a poor
general condition (n 1). The aneurysm-related survival of
patients treated with open repair was 64.3% at 4 years,
compared with 75.2% for patients treated with TEVAR
(P  .191; Fig 2).
Reinterventions during follow-up. In the TEVAR
group, aortic reinterventions were required in 11 patients
during follow-up, because of type one endoleak in eight
patients, an aortoesophageal fistula in one patient, and
Table II. Early outcomes
Open repair
N
Death, stroke, or permanent paraplegia 25
Death 17
Stroke 7
Permanent paraplegia 6
Paraplegia/paraparesis 10
Other complications
Cardiac complications 9
Pulmonary complications 22
Acute renal failure 16
Visceral ischemia 2
Aortic reintervention within 30 days 2
Median length of stay (days) 22
TEVAR, Thoracic endovascular aortic repair.
The median hospital length of stay is shown with the interquartile range and
that suffered stroke after open surgery, six had an anterior circulation stroke a
that developed a stroke after thoracic endovascular aortic repair, four had an
Table III. Independent predictors of death, stroke, or
permanent paraplegia
Variable
Odds
ratio
95% confidence
interval P value
Age 1.04 1.01-1.08 .036
Female gender 0.91 0.40-2.08 .83
Prior aortic repair 2.15 0.95-4.86 .065
Hemothorax 1.29 0.58-2.89 .53
Hypovolemic shock 2.47 1.09-5.60 .030
TEVAR 0.44 0.20-0.95 .039
TEVAR, Thoracic endovascular aortic repair.
Table IV. Independent predictors of 30-day mortality
Variable
Odds
ratio
95% confidence
interval P value
Age 1.01 0.97-1.05 .58
Female gender 0.94 0.36-2.44 .89
Diabetes mellitus 1.48 0.52-4.23 .47
Prior aortic repair 2.65 1.08-6.47 .033
Hemothorax 2.03 0.81-5.07 .13
Hypovolemic shock 2.63 1.03-6.70 .044
TEVAR 0.78 0.29-2.13 .40
TEVAR, Thoracic endovascular aortic repair.aneurysmal dilatation of the thoracic aorta without en- aoleak in two patients. Aortic reinterventions after TEVAR
onsisted of deployment of an additional endograft in nine
atients, coiling in one patient, and surgical resection of a
ype III thoracoabdominal aortic aneurysm in one patient.
n addition, a thorax drain was placed in 22 patients, an
sophagostomy was performed in three patients, and one
atient required a thoracotomy to release trapped lung
issue and evacuate a clotted hemothorax.
In the open surgery group, aortic reinterventions were
equired in three patients during follow-up, which con-
isted of repair of the distal anastomosis because of leakage
n two patients and evacuation of an abscess around the
69) TEVAR (n  92)
P value(%) N (%)
36.2) 20 (21.7) .044
24.6) 16 (17.4) .26
10.1) 7 (7.6) .39
8.7) 2 (2.2) .059
14.5) 7 (7.6) .16
13.0) 5 (5.4) .090
31.9) 16 (17.4) .032
24.6) 8 (8.7) .006
2.9) 0 (0) .18
2.9) 7 (7.6) .30
26) 8 (10) .001
alculated for patients that were discharged alive. Among the seven patients
e patient had a stroke of the posterior circulation. Among the seven patients
or circulation stroke, while three patients had a posterior circulation stroke.
ig 2. Aneurysm-related survival during follow-up after open
epair and thoracic endovascular aortic repair (TEVAR). The
neurysm-related survival of patients treated with open repair was
4.3% at 4 years, compared with 75.2% for patients treated with
EVAR (P  .191).(n 
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May 20111214 Jonker et altracheostomy because of respiratory insufficiency (n 10),
a pneumonectomy (n  1), necrotectomy and debride-
ment (n 1), and a laparotomy because of visceral ischemia
(n  1).
DISCUSSION
TEVAR has revolutionized the management of tho-
racic aortic disease. Advantages of a minimally invasive
endovascular approach are the avoiding of thoracotomy
and aortic cross-clamping, reduced operating times, and
minimal additional blood loss, which are particularly im-
portant in rDTAA patients in critical condition. TEVAR is
emerging as the preferred treatment for patients with
rDTAA at our institutions, although there is currently no
strong evidence that an endovascular approach improves
survival compared with traditional open surgery.
In the present multi-center analysis, we observed a
trend toward reduced 30-day mortality for patients treated
with
TEVAR (17.4% vs 24.6%), in accordance with previous
reports of experienced centers, in which early mortality
rates typically range between 11.4% and 18.9% after
TEVAR16-18 and between 22.2% and 33.3% after surgi-
cal repair.9,18-21 In the United States between 1988 and
2003, the overall in-hospital mortality after open surgi-
cal repair of rDTAA was 45%,6 and the “real world”
mortality rate after intervention for rDTAA may there-
fore be underestimated in the literature. The lower mor-
tality rate after open repair in our evaluation, compared
with this population-based study,6 may be related to the
fact that the participating institutions in our study were
tertiary referral centers, and mortality rates of rDTAA
may be reduced in referral and/or large-volume hospi-
tals.22,23 Furthermore, referred rDTAA patients that
survived transport and received a surgical intervention
may have been relatively more stable, which may have
contributed to improved outcomes as well.
Improved survival after an endovascular approach com-
pared with open surgery has been observed as well for other
thoracic aortic catastrophes, including traumatic aortic in-
juries or complicated type B aortic dissections.13,15,24,25
Although mortality is a very important outcome measure,
the quality of life of surviving patients is also essential when
determining the preferred treatment. In descending tho-
racic aortic interventions, the most feared nonfatal compli-
cation is postoperative paraplegia due to interruption of the
blood supply to the spinal cord. In this study, the incidence
of the composite primary end point of death, stroke, or
paraplegia was significantly reduced after TEVAR, and we
observed a trend toward a lower incidence of permanent
paraplegia in this group. Previous studies have shown a
reduced paraplegia rate after TEVAR for nonruptured
DTAA compared with open surgery.26,27 Theoretic expla-
nations for reduced risks of paraplegia after an endovascular
approach are no aortic cross-clamping during TEVAR,
fewer periods of perioperative hypotension due to blood
loss or hemodynamic shifts, and slow thrombosis of the rneurysm sac compared with acute occlusion of critical
essels during surgical repair.27
Hypovolemic shock at admission was an independent
redictor of both 30-day mortality and the composite end
oint of death, stroke, and paraplegia. Hypovolemic shock
s a strong predictor of death in most acute aortic syn-
romes,16,28-30 and hypovolemia may also lead to inade-
uate perfusion of the spinal cord and brain, resulting in
ncreased risks of neurologic deficits. Aneurysm rupture,
ong cross-clamp duration, and intraoperative hypotension
ave been previously correlated with increased risks of
pinal cord ischemia and stroke during open thoracic aortic
urgery.8,31 Several reports have suggested a similar rela-
ion between emergency procedures, blood loss or peri-
perative hypotension, and the occurrence of spinal cord
schemia after TEVAR.32-35 Prior aortic repair was associ-
ted with an increased risk of 30-day mortality as well.
atients that have undergone prior aortic repair may have
ad a long history of atherosclerotic disease, and a poor
eneral condition, resulting in increased risks of postoper-
tive mortality and morbidity. In addition, open or endo-
ascular repair of rDTAA may be more difficult in a previ-
usly reconstructed aorta.
Although TEVAR was associated with improved out-
omes, a cause for concern is the occurrence of endograft-
elated complications.36,37 Endoleak was diagnosed in 17%
ithin the first 30 days, and aortic reinterventions were
equired in about 8% of all patients during the first month.
urthermore, several patients expired due to infected en-
ografts and/or aortic rupture during follow-up after
EVAR. These findings underline the need for close radio-
ogic surveillance during follow-up after endovascular re-
air of rDTAA, which may be initiated already before
ischarge of the patient. Nevertheless, in the open repair
roup, a considerable number of patients died as well after
he first 30 days, due to multi-organ failure or a poor
eneral condition.
An important limitation of the present study was the
etrospective observational study design. However, due to
he rarity of this condition and its emergent nature, it will
e very difficult to ever realize a large randomized study
omparing the outcomes of TEVAR versus open surgery of
DTAA. Moreover, because of the superior results of TE-
AR for the management of acute thoracic aortic disease in
ultiple observational studies, including the present eval-
ation, conducting such a randomized study may not be
thical. Due to the nonrandomized observational study
esign, baseline differences existed between the treatment
roups, including an older mean age and a smaller aneu-
ysm diameter in the TEVAR group. The older age of the
EVAR patients may be explained by the increasing life
xpectancy of the population, and surgical interventions
ay have been refused to very elderly patients with rDTAA
rior to the endovascular era. There may be several theo-
etic explanations for the smaller mean aneurysm diameter
n the TEVAR group. The proportion of patients with
neurysms 5.5 cm undergoing elective thoracic aortic
epair has increased over the years, due to increased detec-
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mentmodalities and outcomes.38,39 This may have resulted
in a lower occurrence of rupture of very large aneurysms,
and therefore a relative increase in the occurrence of aortic
rupture of aneurysms smaller than 5.5 cm. In addition, very
large aneurysms may be more often unsuitable for an
endovascular approach, due to inadequate landing zones.
In a recent comparative analysis of Patel and colleagues,
patients treated with TEVAR for thoracic aortic rupture
were significantly older and had a smaller mean aortic
diameter as well, when compared with patients treated with
open surgery.16 Another limitation of the study is that most
open surgical interventions were performed before 2000,
while all endovascular procedures were performed after
2000 in our evaluation, and the outcomes of open surgery
for rDTAA may have improved slightly over the years.
However, due to the low incidence of rDTAA and the
increasing utilization of TEVAR, it is very difficult to obtain
a considerable number of rDTAA patients treated with
open surgery in more recent years.
CONCLUSIONS
There has been a shift toward endovascular manage-
ment of patients with rDTAA at our institutions. We ob-
served a lower rate of the composite end point of death,
stroke, and paraplegia, for the rDTAA patients treated with
TEVAR compared with traditional open surgery. Further-
more, there was a trend toward lower risks of permanent
paraplegia and improved aneurysm-related survival after
TEVAR. In rDTAA patients, endovascular management
appears the preferred treatment when this method is feasi-
ble.
We would like to thank Michelle Streukens for the data
collection.
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Ruptured thoracic aortic aneurysms represent a formidable
aortic catastrophe. A Swedish study from the pre-endovascular era
found that 54% of patients died within the first 6 hours, 41%
reached the hospital alive, and only 3% survived hospitalization.1
Despite advances, open repair of ruptured descending thoracic
aortic aneurysms (rDTAAs) continue to carry highmortality (45%)
on a recent review of national outcomes.2 Since the first report of
a thoracic endovascular aneurysm repair (TEVAR) by Dake and
colleagues in 1994, this technique has been shown to reduce early
mortality, morbidity, length of stay, and spinal cord injury rates
compared with open repair.3-5 Currently, TEVAR has become the
primary method of treatment in most centers for intact or ruptured
thoracic aneurysms, penetrating ulcers, intramural hematomas,
and traumatic transections.
In this issue of the Journal, Jonker and colleagues are to be
congratulated for their report on the largest multicenter retrospec-
tive analysis of open versus endovascular techniques for treatment
of rDTAAs.6 The study has confirmed with “real world” data that
the utilization of open repair was decreased from 100% prior to
2000 to 10% since 2005, when thoracic stent grafts became
commercially available in the United States. The decreasing num-
ber of open repairs coincided with a trend toward decreased
mortality: 32% prior to 2000 (open era), 21% between 2001 and
2004 (transitional era), and 15% after 2005 (endovascular era).
The primary end point of the study was a composite of death,
stroke, and paraplegia, and was significantly less frequent in the
TEVAR (22%) compared with the open repair group (32%). The
study had important limitations, namely the retrospective de-
sign, selection bias, lack of anatomical analysis of the extent of
aneurysm, and relative small number of patients to allow analysis
of factors associated with death, paraplegia, stroke, dialysis, and
reinterventions. Nevertheless, these findings are in concert with
other retrospective reviews, including reports of national data-ave confirmed the superiority of TEVAR for intact and rup-
ured thoracic aneurysms.3-5
Most would agree that TEVAR simplifies and expedites treat-
ent of acute thoracic aortic emergencies. The advantages are
umerous, including no thoracotomy, cardiopulmonary bypass,
ypothermic cardiac arrest, or aortic cross-clamping, minimizing
perative time, blood loss, and fluid requirements, with a minimally
nvasive approach. Still, there are limitations that impede the
idespread use of TEVAR in some patients, because of anatomical
onstraints related to the quality of the landing zones, difficult iliac
ccess, and need to carry a wide range of stent graft sizes off-the-
helf for emergent use. However, as aortic endograft technology
volves and becomes more available to the vascular community,
EVAR indications will continue to expand to patients with more
hallenging anatomy.
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